Spots Global Cancer Trial Database for A Study of Olaratumab (IMC-3G3) in Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Olaratumab (IMC-3G3) in Prostate Cancer
Official Title: A Randomized Phase 2 Study of Human Anti-PDGFRα Monoclonal Antibody IMC-3G3 Plus Mitoxantrone Plus Prednisone or Mitoxantrone Plus Prednisone in Metastatic Castration-Refractory Prostate Cancer Following Disease Progression or Intolerance on Docetaxel-based Chemotherapy
Study ID: NCT01204710
Conditions
Study Description
Brief Summary: This is a study evaluating the safety and efficacy of the monoclonal antibody olaratumab plus mitoxantrone plus prednisone compared to mitoxantrone plus prednisone in metastatic castration-refractory prostate cancer following disease progression or intolerance on docetaxel-based chemotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
ImClone Investigational Site, Charleroi, , Belgium
ImClone Investigational Site, Edegem, , Belgium
ImClone Investigational Site, Liège, , Belgium
ImClone Investigational Site, Olomouc, , Czechia
ImClone Investigational Site, Prague, , Czechia
ImClone Investigational Site, Praha 5, , Czechia
ImClone Investigational Site, Aachen, , Germany
ImClone Investigational Site, Augsburg, , Germany
ImClone Investigational Site, Bonn, , Germany
ImClone Investigational Site, Dresden, , Germany
ImClone Investigational Site, Essen, , Germany
ImClone Investigational Site, Frankfurt, , Germany
ImClone Investigational Site, Freiburg, , Germany
ImClone Investigational Site, Mainz, , Germany
ImClone Investigational Site, Mannheim, , Germany
ImClone Investigational Site, Münster, , Germany
ImClone Investigational Site, Rostock, , Germany
ImClone Investigational Site, Budapest, , Hungary
ImClone Investigational Site, Debrecen, , Hungary
ImClone Investigational Site, Kecskemét, , Hungary
ImClone Investigational Site, Miskolc, , Hungary
ImClone Investigational Site, Nyíregyháza, , Hungary
ImClone Investigational Site, Pécs, , Hungary
ImClone Investigational Site, Szeged, , Hungary
ImClone Investigational Site, Meldola, , Italy
ImClone Investigational Site, Milano, , Italy
ImClone Investigational Site, Roma, , Italy
ImClone Investigational Site, Rozzano, , Italy
ImClone Investigational Site, Trento, , Italy
ImClone Investigational Site, Kraków, , Poland
ImClone Investigational Site, Lublin, , Poland
ImClone Investigational Site, Poznań, , Poland
ImClone Investigational Site, Warszawa, , Poland
ImClone Investigational Site, Barcelona, , Spain
ImClone Investigational Site, Barcelona, , Spain
ImClone Investigational Site, Madrid, , Spain
ImClone Investigational Site, Palma de Mallorca, , Spain
ImClone Investigational Site, Pamplona - Navarra, , Spain
ImClone Investigational Site, Sabadell - Barcelona, , Spain
ImClone Investigational Site, Valencia, , Spain
Contact Details
Name: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Affiliation: Eli Lilly and Company
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
